Migraine and aura characteristics, patient demographics, dosages of lamotrigine, and treatment duration
| Parameter | N/(%) | Mean | SD | Range |
|---|---|---|---|---|
| Migraine with aura | 56/(95) | |||
| Aura without headache | 3/(5) | |||
| Patients total | 59/(100) | |||
| Type of aura | ||||
| Visual | 20/(34) | |||
| Sensory | 14/(24) | |||
| Visual and sensory | 14/(24) | |||
| Unilateral paresis | 5/(8) | |||
| Bilateral paresis arm/leg | 3/(5) | |||
| Dysarthria/speech deficits | 3/(5) | |||
| Sex (F/M) | 35(59)/24(41) | |||
| Age (years) | 59 | 32.1 | 8.7 | 18–52 |
| Duration of disease (years) | 59 | 6.3 | 3.8 | 1–20 |
| Aura frequency (each month) | 59 | 1.5 | 0.6 | 1–3 |
| Duration of aura (minutes) | 59 | 26.9 | 10.8 | 10–50 |
| Migraine attack frequency (months) | 56 | 2.1 | 1.0 | 1–6 |
| Lamotrigine dosage (mg) | 59 | 166.94 | 93.7 | 50–300 |
| Treatment time to reach primary endpoint (months) | 59 | 4.8 | 2.3 | 2–14 |